Adult dermatomyositis is an idiopathic inflammatory myopathy (IIM). In cases where the disease proves refractory — not achieving adequate control — a specific, evidence-supported treatment option is recommended.
Refractory adult idiopathic inflammatory myopathy (IIM), including dermatomyositis, where disease activity has not been sufficiently controlled.
For refractory adult IIM, a biologic agent with a specific mechanism of action is indicated as a treatment option. The complete protocol — including agent selection, sequencing, and the full structured regimen — is available via the link below.
DOI: 10.1093/rheumatology/keac115
Abatacept is to be considered as a treatment option in refractory adult IIM.
View source ↗